Batallé Gerard, Bai Xue, Pouso-Vázquez Enric, Roch Gerad, Rodríguez Laura, Pol Olga
Grup de Neurofarmacologia Molecular, Institut d'Investigació Biomèdica Sant Pau, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Grup de Neurofarmacologia Molecular, Institut de Neurociències, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
Antioxidants (Basel). 2021 Oct 16;10(10):1632. doi: 10.3390/antiox10101632.
Chronic osteoarthritis pain is accompanied by several comorbidities whose treatment has not been completely resolved. The anti-inflammatory, analgesic, and antidepressant effects of slow-releasing hydrogen sulfide (HS) donors during osteoarthritic pain have been shown, but their actions in the accompanying memory impairment and anxious-like behaviors have not yet been demonstrated. Using female mice with chronic osteoarthritic pain, the effects of natural, diallyl disulfide (DADS) or synthetic, morpholin-4-ium 4-methoxyphenyl(morpholino) phosphinodithioate dichloromethane complex (GYY4137) slow-releasing HS donors, on associated cognitive and grip strength deficits and anxiodepressive-like behaviors, were assessed. Their effects on specific brain areas implicated in the modulation of pain and emotional responses were also determined. Results demonstrated an improvement in memory and grip strength deficits, as well as in the anxious-like behaviors associated with chronic pain in GYY4137 and/or DADS treated mice. The painkiller and antidepressant properties of both treatments were also established. Treatment with DADS and/or GYY4137 inhibited: oxidative stress in the amygdala; phosphoinositide 3-kinase overexpression in the amygdala, periaqueductal gray matter, and anterior cingulate cortex; protein kinase B activation in the amygdala and infralimbic cortex; up-regulation of inducible nitric oxide synthase in the amygdala, periaqueductal gray matter and infralimbic cortex and apoptotic responses in the amygdala. These results might explain the recovery of memory and grip strength and the inhibition of allodynia and associated anxiodepressive-like behaviors by these treatments. In conclusion, this study revealed new properties of slow-releasing HS donors in cognitive impairment and affective disorders linked with chronic osteoarthritis pain and their effects on the central nervous system.
慢性骨关节炎疼痛伴有多种尚未完全解决治疗问题的合并症。已证实缓释硫化氢(HS)供体在骨关节炎疼痛期间具有抗炎、镇痛和抗抑郁作用,但其对伴随的记忆障碍和焦虑样行为的作用尚未得到证实。使用患有慢性骨关节炎疼痛的雌性小鼠,评估了天然的二烯丙基二硫化物(DADS)或合成的吗啉 - 4 - 鎓4 - 甲氧基苯基(吗啉代)膦二硫代酸二氯甲烷络合物(GYY4137)缓释HS供体对相关认知和握力缺陷以及焦虑抑郁样行为的影响。还确定了它们对与疼痛和情绪反应调节相关的特定脑区的影响。结果表明,GYY4137和/或DADS处理的小鼠在记忆和握力缺陷以及与慢性疼痛相关的焦虑样行为方面有所改善。两种治疗方法的止痛和抗抑郁特性也得到了证实。DADS和/或GYY4137处理可抑制:杏仁核中的氧化应激;杏仁核、导水管周围灰质和前扣带回皮质中磷酸肌醇3 - 激酶的过表达;杏仁核和边缘下皮质中蛋白激酶B的激活;杏仁核、导水管周围灰质和边缘下皮质中诱导型一氧化氮合酶的上调以及杏仁核中的凋亡反应。这些结果可能解释了这些治疗方法如何恢复记忆和握力以及抑制异常性疼痛和相关的焦虑抑郁样行为。总之,本研究揭示了缓释HS供体在与慢性骨关节炎疼痛相关的认知障碍和情感障碍中的新特性及其对中枢神经系统的影响。